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Abstract.  In the rat optic nerve, bipotential O-2A 
progenitor cells give rise to oligodendrocytes and type 
2 astrocytes on a precise schedule. Previous studies 
suggest that PDGF plays an important part in timing 
oligodendrocyte development by stimulating O-2A pro- 
genitor cells to proliferate until they become mitoti- 
cally unresponsive to PDGE stop dividing, and 
differentiate automatically into oligodendrocytes. Since 
the loss of mitotic responsiveness to PDGF has been 
shown not to be due to a loss of PDGF receptors, we 
have now examined the possibility that the unrespon- 
siveness results from an uncoupling of these receptors 
from early intracellular signaling pathways. 
We show that (a) although PDGF does not stimulate 
newly formed oligodendrocytes to synthesize DNA, it 
induces an increase in cytosolic Ca  2+ in these cells; (b) 
a combination of a Ca  2+ ionophore plus a phorbol es- 
ter mimics the effect of PDGF, both in stimulating 
O-2A progenitor cell division and in reconstituting the 
normal timing of oligodendrocyte differentiation in cul- 
ture; and (c) the same combination of drugs does not 
stimulate newly formed oligodendrocytes to proliferate, 
even in the presence of PDGF or dibutyryl cAMP. 
The most parsimonious explanation for these results is 
that O-2A progenitor cells become mitotically un- 
responsive to PDGF because the intracellular signaling 
pathways from the PDGF receptor to the nucleus are 
blocked downstream from the receptor and some of 
the early events that are triggered by receptor acti- 
vation. 
T 
HE rat optic nerve contains three types of macroglial 
cell, which develop on a precise schedule. Type 1 as- 
trocytes develop before birth from their own precursor 
cells (Raft et al., 1984), whereas both oligodendrocytes  and 
type 2 astrocytes develop after birth from bipotential O-2A 
progenitor cells (Raft et al.,  1983b; Miller et al.,  1985). 
Oligodendrocytes  first appear around the time of  birth, while 
type 2 astroeytes first appear in the second postnatal  week 
(Miller et al.,  1985). 
The timing and direction of O-2A progenitor cell differen- 
tiation depend on both an intrinsic developmental program 
in the cell and on cell-cell interactions (Raft,  1989). When 
progenitor cells in vitro are deprived of their normal en- 
vironmental signals, they stop dividing and differentiate pre- 
maturely into oligodendrocytes (Temple and Raft,  1985), 
suggesting that this is the constitutive pathway of  differentia- 
tion, which is triggered automatically when progenitor cells 
stop dividing.  Type 2 astrocyte differentiation,  by contrast, 
seems to depend on extracellular inducing signals, which be- 
gin to operate in the second posmatal  week (Temple and 
Raft,  1985; Hughes and Raft,  1987; Hughes et al.,  1988; 
Lillien et al.,  1988). 
PDGF, secreted by type 1 astrocytes, plays a crucial role 
in amplifying the number of O-2A progenitor cells (Noble 
et al.,  1988; Richardson et al.,  1988; Pringle et al.,  1989) 
and in timing oligodendrocyte  differentiation in culture (Raft 
et al., 1988). PDGF is thought to act directly on O-2A pro- 
genitor cells (Hart et al., 1989) to stimulate their prolifera- 
tion until an intrinsic timer in the cells causes them to be- 
come mitotically  unresponsive  to PDGF; as a  result, the 
cells stop dividing and differentiate  into oligodendrocytes 
(Raft et al.,  1985, 1988). 
What is the nature of the timer that controls the onset of 
mitotic unresponsiveness  to PDGF? One possibility is that 
a molecule required for the proliferative response to PDGF 
decreases with time, or with each successive cell division, 
until it falls below a threshold level (Raff  et al., 1985; Temple 
and Raft, 1986). We have shown previously that many newly 
formed oligodendrocytes,  which no  longer divide in  re- 
sponse to PDGF, still express large numbers of PDGF recep- 
tors, making it unlikely that receptor loss is responsible for 
the loss  of mitotic responsiveness  to PDGF (Hart et al., 
1989). 
In 3T3 cells, PDGF activates multiple intracellular signal- 
ing pathways (Rozengurt,  1986; Williams,  1989), including 
the inositol phospholipid  pathway (Habenicht et al.,  1981; 
Matuoka et al.,  1988; Meisenhelder et al.,  1989),  which 
leads to protein kinase C (C-kinase)~ activation (Rozengurt 
et al.,  1983a) and an elevation of cytosolic Ca  2+ (lves and 
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1983b),  which leads to the activation of cAMP-dependent 
protein kinase (A-kinase). In addition, PDGF receptors are 
tyrosine kinases (Yarden et al., 1986; Claesson-Welsh et al., 
1988;  Gronwald et al.,  1988;  Matsui et al,,  1989),  which 
phosphorylate both themselves and other target proteins in 
the cell (Escobedo et al., 1988;  Williams, 1989)  including 
the tyrosine kinase c-src  (Ralston and Bishop, 1985), a phos- 
phatidylinositol kinase (Coughlin et al., 1989), and the ser- 
ine/threonine kinase Raf-I (Morrison et al., 1988).  It is not 
known how these various intracellular signaling pathways 
lead to cell division. 
In the present study, we have examined the possibility that 
O-2A progenitor cells become mitotically unresponsive to 
PDGF because their PDGF  receptors  become uncoupled 
from the inositol phospholipid or cAMP signaling pathways. 
Because the other signaling pathways activated by PDGF are 
poorly understood, they were not specifically investigated. 
We show that, although newly formed oligodendrocytes do 
not respond mitotically to PDGF,  PDGF can stimulate a 
rapid increase in cytosolic Ca  ~÷ in these cells as well as in 
progenitor cells. We also show that O-2A progenitor cells 
can be stimulated to divide and differentiate into oligoden- 
drocytes on schedule when their cytosolic Ca  2÷ levels  are 
raised with a  Ca  2÷ ionophore and, at the same time, their 
C-kinases are activated by a phorbol ester; the same combi- 
nation of drugs, however, does not stimulate newly formed 
oligodendrocytes  to synthesize DNA, even in the presence of 
dibutyryl cAMP (dbcAMP) or PDGE  Finally, we demon- 
strate that PDGF,  but not the combination of Ca  2÷  iono- 
phore and phorbol ester, is still mitogenic for O-2A progeni- 
tor cells in which C-kinase has been downregulated. Taken 
together, these findings suggest that the reason O-2A progen- 
itor cells become mitotically unresponsive to PDGF cannot 
be solely that their PDGF receptors are functionally uncou- 
pled from early intracellular signaling events; there must be 
a block in the intracellular mitotic response pathways down- 
stream from these events. 
Materials and Methods 
Cell Culture 
Optic nerves were dissected from embryonic day-18, newborn, or postnatal 
day-2, -7, or -15 Sprague-Dawley rats and dissociated into single cells using 
trypsin,  EDTA,  and collagenase, as previously described (Miller et al., 
1985).  About 5,000-20,000  cells were cultured at  37°C  in 5%  CO2  on 
poly-D-lysine-coated  glass coverslips in 0.5 ml serum-free DME containing 
additives previously described by Bottenstein (1986). 
Cells for culture in microwells were diluted in L-15  medium (Gibco 
Laboratories, Grand Island, NY) containing 10% FCS. About five cells in 
10 t~l medium were transferred to single wells of a Terasaki microculture 
plate (Falcon Labware, Oxnard, CA) that had previously been coated with 
poly-D-lysine and then incubated with supplemented DME for 2 h at 37°C. 
The cells were incubated at 37°C in air for 30 min to allow them to adhere, 
the medium was then changed to astrocyte-conditioned  medium diluted 1:20 
with supplemented DME, and the plates were then incubated at 37°C in 5% 
CO2.  The astrocyte-conditioned medium was prepared as previously de- 
scribed (Raft et aL, 1988);  it was used to increase the survival of isolated 
cells but had no mitogenic effect at this dilution. 
Downregulation of C-kinase 
For C-kinase downregulation experiments (Collins and Rozengurt, 1984), 
newborn optic nerve ceils were cultured on coverslips in supplemented 
DME with a high concentration of phorbol 12,13 dibutyrate (PDB;  10  4 
M) for 12 h. The cells were then transferred to supplemented DME contain- 
ing 0.1% BSA for 30 min to remove the PDB, then rinsed, transferred to 
supplemented DME, and cultured for an additional 36 h with either PDB 
(10  -s M) plus the Ca  2+ ionophore A23187  (A23187)  (10 "9 M) or human 
PDGF (2 ng/ml). 
Bromodeoxyuridine (BrdU) Incorporation and 
Immunofluorescence Staining 
BrdU (Boehringer Mannheim GmbH, Mannheirn, FRG), which is incorpo- 
rated into replicating DNA (Gratzner, 1982), was added to cultures of optic 
nerve cells to a final concentration of 5  x  10  -s M for the last 24 h of the 
culture period. After fixation with 4% paraformaldehyde for 2 min at room 
temperature, cells were surface stained either with monoclonal anti-galac- 
tocerebroside (GC) antibody (Ranscht et al.,  1982;  ascites fluid diluted 
1:100)  followed by fluorescein-coupled, class-specific, goat anti-mouse 
IgG3  (Nordic  Immunological  Laboratories,  Tilburg,  The  Netherlands; 
diluted 1:100) or with the A2B5 monoclonal antibody (Eisenbarth et al., 
1979;  ascites fluid diluted  1:100) followed either by fluorescein-coupled 
goat  anti-mouse Ig  (Cappel  Laboratories,  Malvern,  PA;  diluted  1:100) 
or by biotin-coupled sheep anti-mouse Ig (Amersham Corp., Arlington 
Heights,  IL;  diluted  1:50)  followed by  fluorescein-coupled streptavidin 
(Amersham Corp., diluted  1:50)~ The antibodies were diluted in MEM 
buffered with 0.02 M Hepes and containing 10%  FCS and 0.2% (wt/vol) 
sodium azide. Cells were postfixed in glacial acetic acid/ethanol (5:95) at 
-20°C for 10 min. They were then treated with 2 N HCI to denature the 
nuclear DNA (Yong and Kim, 1987) followed by 0.1 M sodium borosilicate, 
pH 8.5, both for 10 min at room temperature. The cells were then labeled 
with monoclonal anti-BrdU antibody (Magaud et al., 1988; culture super- 
natant diluted 1:2 in PBS containing 1% Triton X-100 and 2% FCS) followed 
by rhodamirte-coupled goat anti-mouse Ig (Cappel Laboratories; diluted 
l:100 in the same solution). In some experiments, cells were stained with 
a  rabbit antiserum against gila/ fibrillary acidic protein (GFAP) (Pruss, 
1979; diluted 1:1,000). In these cases, the cells were prefixed with 70% eth- 
anol for 30 min at -20°C, the bound anti-GFAP antibodies were detected 
with fluorescein-coupled sheep anti-rabbit Ig  (Wellcome Reagent Ltd., 
Beckenham, England; diluted 1:1,000), and the cells were then prepared for 
BrdU labeling as before. 
Cells on coverslips were mounted in Citifluor (City University, London, 
England)  on  glass  slides and  sealed  with  nail  varnish,  while cells  in 
microwells were viewed after the addition of PBS containing 0.1% p-pbenyl- 
enediamine to prevent fading of fluorescence. The cells were then examined 
in a Universal fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY) 
using a 40x or 63 x objective and photographed using Tri-X film (ASA 400) 
(Eastman Kodak Co., Rochester, NY). 
Gtiat cell types were identified by their characteristic morphologies and 
antigenic phenotypes: astrocytes were labeled by anti-GFAP antiserum 
(Bignami et al.,  1972),  O-2A progenitor cells by A2B5 monoclonal anti- 
body (Raffet al., 1983b),  and oligodendrocytes by anti-GC antibody (Raft 
et al.,  1978). 
Measurement of Cytosolic Ca  ~÷ 
Postnatal day-2  optic nerve cells were cultured for 1 d  in supplemented 
DME (without PDGF) on poly-D-iysine-coated glass coverslips on which 
a grid had been drawn in indelible ink. The cells were incubated with the 
tetra-acetoxymethyl ester of the fluorescent Ca  2+  indicator fura-2  (fura- 
2AM; 4 ttM) in supplemented DME for 30 rain at room temperature. The 
fura-2AM was aspirated, and the cells were incubated in I..-15 medium for 
a further 90 min at 37°C in air before they were examined in a fluorescence 
microscope (Carl Zeiss, Inc.) adapted to alternate rapidly between the exci- 
tation wavelengths of 350 and 380 nm. A field of cells was visualized via 
a television camera connected to an image processor, and the fluorescence 
was recorded for at least 10 min before and 10 min after the addition of 
PDGF  (2  ng/ml).  Free Ca  2+  levels were calculated for individual cells 
within the field as described previously (Silver et al., 1989).  In control ex- 
periments, the vehicle used to suspend the PDGF (10 mM acetic acid con- 
taining 2 mg/ml BSA) was added to the cultures. Photographs of the cells 
were taken on Instamatic film (Polaroid Corp., Cambridge, MA), and the 
cells were then immunolabeled as described above to aid identification; the 
field of interest was relocated using the photographs and the ink grid on 
the coverslip. 
Although 4 #M was the lowest concentration of fura-2AM that gave ade- 
quate loading of O-2A lineage cells, these cells did not tolerate the proce- 
dure well: some showed a spontaneous gradual rise in cytosolic free Ca  2* 
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Such cells were not included in the analysis. 
Materials 
Human PDGF was obtained from R and D Systems Inc. (Minneapolis, MN) 
and goat anti-human PDGF antibodies (an IgG fraction prepared by ion ex- 
change chromatography) were purchased from Collaborative Research Inc. 
(Waltham, MA).  Forskolin,  PDB, phorbol  12-myristate 13  acetate, 4a- 
phorbol  12,13-didecanoate, dbcAMP, A23187, and arachidonic acid were 
obtained from Sigma Chemical Co. (St. Louis, MO), and fura-2AM was 
from Molecular Probes Inc. (Junction City, OR). 
Results 
PDGF Causes a Rapid Increase in Cytosolic Ca  2÷ in 
Newly Formed Oligodendrocytes 
We found previously that many newly formed oligodendro- 
cytes have large numbers of PDGF receptors even though 
they  are  mitotically unresponsive to  PDGF  (Hart et al., 
1989). To determine if the PDGF receptors on these cells are 
functional, we studied the effect of PDGF on cytosolic Ca  2+ 
levels in postnatal day-2 optic nerve cells that were cultured 
for 1 d and then loaded with fura-2AM. The cytosolic free 
Ca  2÷ concentration was determined in individual cells be- 
fore and after PDGF was added to the cultures. The oligo- 
dendrocytes were initially identified by their characteristic 
morphology,  and  the  assignments  were  later checked  by 
labeling with anti-GC antibodies (Raft et al.,  1978).  In  12 
experiments,  12 out of 22 GC  ÷ oligodendrocytes showed a 
rise in cytosolic free Ca  2÷ when PDGF (2 ng/ml) was added. 
In some of these cases, the increase was small (<100 nM), 
occurred slowly (reaching a peak in >200 s), or quantitative 
data were incomplete. In the 17 cells where quantitative data 
were available, 5 showed an increase in cytosolic free Ca  2÷ 
(from 82  +  19 nM to 277  5-  15 nM) within 21-200 s after 
addition of PDGF (Fig. 1). Although there was a mixture of 
strongly and weakly GC  + oligodendrocytes in these cultures, 
all of the oligodendrocytes that showed a Ca  2÷ response were 
weakly GC  ÷, suggesting that they had only recently differ- 
entiated. This is consistent with our previous findings that 
oligodendrocytes  tend to lose PDGF receptors as they mature 
(Hart et al.,  1989).  In control experiments, no change in 
cytosolic free Ca  2÷ levels were observed in 20  out of 20 
oligodendrocytes after addition of the vehicle used to dis- 
solve the PDGE  Thus,  PDGF receptors on at least some 
newly formed oligodendrocytes could be activated by PDGF 
to cause an increase in cytosolic Ca  2÷. 
As expected, some of the O-2A progenitor cells in these 
cultures (identified by immunolabeling with A2B5 antibody; 
Raft et al.,  1983b;  Temple and Raft,  1986) also showed a 
Ca  2+  response  to  PDGE  although  fewer cells  responded 
than anticipated. In 12 experiments, 13 out of 52 progenitor 
cells showed a response, and, in the 48 cells in which quan- 
titative data were complete, 8 showed a rise in cytosolic free 
Ca  2+ (from 64  5-  8 nM to 152  +  33 nM) within 28-266 s 
after addition of PDGE In control experiments, 25 out of 25 
progenitor cells showed no response when vehicle was added 
to the cultures without PDGE The low proportion of  progen- 
itor cells that responded to PDGF, compared with the much 
higher proportion ('~70-80%)  that  would be expected to 
have PDGF receptors (Hart et al.,  1989), was probably due 
to the sensitivity of these cells to the damaging effects of 
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Figure 1.  Effect of PDGF on cytosolic Ca  2+ in a newly formed 
oligodendrocyte in culture. Postnatal day-2 optic nerve cells were 
cultured in serum-free medium for 1 d and then loaded with fura- 
2AM.  The cytosolic free Ca  2+ concentration was determined in 
this cell before and after PDGF (2 ng/ml) was added to the culture. 
The oligodendrocyte was initially identified by morphology and was 
found to be weakly stained after the culture was labeled with an- 
ti-GC antibody. 
loading with fura-2AM (see Materials and Methods). O-2A 
progenitor cells have been found to be unusually sensitive to 
suboptimal culture conditions and to various physical and 
chemical manipulations (Raft, M. C., unpublished observa- 
tions). 
64 out of 64 type 1 astrocytes showed no change in cyto- 
solic free Ca  2÷ levels after addition of PDGF (from an aver- 
age resting level of 87 +  6 nM). These results are consistent 
with our previous finding that type 1 astrocytes do not have 
PDGF receptors (Hart et al.,  1989). 
A Combination of  PDB and A23187 Stimulates O-2A 
Progenitor Cells To Synthesize DNA 
To study the effects of manipulating intracellular signaling 
pathways on DNA synthesis in O-2A progenitor cells,  we 
cultured optic nerve cells from newborn rats in serum-free 
medium for 2 d in the presence of various agents. BrdU was 
added for the last 24 h of  the culture period and the cells were 
then double labeled by indirect immunofluorescence with the 
A2B5 monoclonal antibody to identify the progenitor cells 
and with monoclonal anti-BrdU antibody to identify cells 
that had incorporated BrdU into DNA (Magaud et al., 1988) 
(Fig. 2). 
When newborn optic nerve cells were cultured in the ab- 
sence of drugs,  <5 %  of the O-2A progenitor cells incor- 
porated BrdU. When added individually, none of the follow- 
ing agents had a detectable effect on BrdU incorporation in 
progenitor cells: arachidonic acid (10-7-10 -~ M),  dbcAMP 
(10-6-10 -3 M),  forskolin (an activator of adenylate cyclase; 
10-8-10  -3 M), PDB (a phorbol ester that activates C-kinase; 
10-'2-10 -6 M), or A23187 (a Ca  2+ ionophore; 10-12-10-6 M) 
(not shown). A combination of PDB and A23187,  however, 
did  stimulate progenitor cells to synthesize DNA,  with a 
maximal effect at  10  -8 and  10  -9 M,  respectively (Fig.  3). 
This stimulation almost equaled the effect of PDGF, which 
has been shown previously to be a potent mitogen for O-2A 
progenitor cells in culture (Noble et al.,  1988; Richardson 
et al.,  1988; Pringle et al., 1989). When 4c~-phorbol  12,13- 
didecanoate, an inactive isomer of PDB, was used in place 
of PDB, no stimulation was seen with A23187 (not shown), 
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graphs of O-2A progenitor cells stimu- 
lated to incorporate BrdU in response to 
A23187 plus PDB. Newborn day-7 optic 
nerve cells were cultured in serum-free 
medium for 2 d with A23187 (10  -9 M) 
plus  PDB (10  -8 M).  BrdU was added 
for the last 24 h of the culture period, 
and the cells were double labeled with 
A2B5 antibody, followed by biotin-cou- 
pled sheep anti-mouse Ig and then fluo- 
rescein-coupled  streptavidin, and  then 
with  anti-BrdU  antibody, followed by 
rhodamine-coupled goat anti-mouse lg. 
"rbe  cei~  wre ~  ~ii~  ~- 
contrast (a), fluoreseein (b), or rhoda- 
mine (c) optics. One of the two A2B5  +, 
prneess-beariog progenitor cells shown 
in a and b is seen to be BrdU  + in c. Bar, 
20 #m. 
suggesting that the observed effect of PDB (when used with 
A23187) depended on the specific activation of C-kinase. 
Another phorbol ester, phorbol 12-myristate 13-acetate,  when 
used together with A23187, also stimulated O-2A progenitor 
cells to synthesize DNA, but only if 0.5% FCS was added 
to the medium (not shown). We have no explanation for this 
difference  between PDB and phorbol 12-myristate 13-acetate. 
A23187 or PDB were without effect when they were com- 
bined with forskolin or dbcAMP  (not shown),  suggesting 
that the activation of A-kinase, in combination with either an 
increase  in  cytosolic Ca  2+  or  the  activation of C-kinase, 
does not stimulate DNA synthesis in these cells. 
PDB and A23187 Act Directly on O-2A Progenitor 
Cells To Samulate DNA Synthesis 
It was  important to determine whether PDB and  A23187 
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Figure 3. Effect of A23187 plus PDB on BrdU incorporation in 
O-2A progenitor cells in culture. Newborn optic nerve cells were 
cultured in serum-free medium for 2 d without additives or with 
either  A23187 (10  -9  M)  plus varying concentrations of PDB or 
PDGF (2 og/ml). BrdU was added for the last 24 h of the culture 
period,  and the cells were double labeled with A2B5 and anti- 
BrdU antibodies. The O-2A progenitor cells  were identified as 
A2B5  +, process-bearing ceils (see Fig. 2). The results in this figure 
and in Table II are expressed as mean + SEM of  three experiments. 
other cell type. It was possible, for example, that the drugs 
were stimulating type 1 astrocytes to secrete PDGF, which 
in turn stimulated the progenitor cells to synthesize DNA. 
To study the responses of progenitor cells in the absence of 
type 1 astrocytes, we studied low density cultures (<5,000 
cells per coverslip) of  optic nerve cells from postnatal day-15 
rats. It has been shown previously that relatively few type 1 
astrocytes are released from later than postnatal day-7 optic 
nerves by the dissociation procedure used  (Miller et al., 
1985). In three experiments on postnatal day-15 cells, 34 + 
5 % of the O-2A progenitor cells were stimulated to incor- 
porate BrdU by the combination of PDB and A23187 com- 
pared with <1% in control cultures; in sister cultures, PDGF 
stimulated 23  +  6% of the progenitor cells to incorporate 
BrdU.  There were no type  1 astrocytes (as determined by 
anti-GFAP staining and morphology; Raft et al.,  1983a) in 
any of these cultures, although GFAP- fibroblast-like cells 
accounted for ~-,5  % of  the population. Moreover, in three ex- 
periments, the addition of goat anti-PDGF antibodies (90 
~g/ml of  IgG) to 2-d-old bulk cultures of  postuatal day-7 optic 
nerve cells did not inhibit the ability of PDB plus A23187 
to stimulate O-2A progenitor cells to synthesize DNA, even 
though the same concentration of anti-PDGF antibodies al- 
most completely neutralized the effect of  4 ng/ml PDGF (not 
shown). 
To further assess whether PDB and A23187 acted directly 
on O-2A  progenitor cells to  stimulate them to  synthesize 
DNA, single-ceU cultures were prepared from postnatal day-7 
optic nerves by limiting dilution in microwells, as previously 
described (Hughes and Raft, 1987). In microwells that con- 
tained only O-2A progenitor cells, as assessed by morphol- 
ogy and immunofluorescence staining with A2B5, PDB plus 
A23187 stimulated BrdU incorporation almost to the same 
extent as PDGF (Table I), suggesting that all of these agents 
act directly on the progenitor cells to induce DNA synthesis. 
A  Combination of  PDB and A23187 
Reconstitutes Normal ~ming of Oligodendrocyte 
Differentiation in Culture 
To determine whether PDB plus A23187 could also stimulate 
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by O-2A Progenitor Cells in Single-cell MicroweU Cultures 
Agent added 
O-2A progenitor cells incorporating BrdU (the 
number of BrdU  + progenitor cells out of total 
progenitor cells assessed) 
% 
Control  6  (8 out of 127) 
PDGF  38 (96 out of 256) 
PDB  +  A23187  30 (54 out of 188) 
Postnatal day-7 optic nerve ceils were plated in microwells (less than or equal 
to five cells per well) and cultured for 2 d without additives or with either PBD 
(10  -8 M) plus A23187 (10  -9 M) or PDGF (2 ng/ml). BrdU was added for the 
last 24 h of the culture period and the cells were quadruple labeled with A2BS, 
anti-GC, anti-GFAP, and anti-BrdU antibodies. Only microwells that con- 
tained a single O-2A progenitor cell (A2B5  +, GC-, GFAP-, process bearing) 
and no other cells were included in the results shown. 
progenitor cell proliferation and reconstitute the normal in 
vivo timing of oligodendrocyte differentiation in vitro, we 
cultured embryonic day-18 optic nerve cells for 1, 2, and 3 d 
with PDB and A23187. A small amount of FCS (0.5 %) was 
added to the medium since it improved cell survival. As de- 
scribed  previously  (Raft et al.,  1985, 1988),  in  cultures 
maintained without added mitogens, many O-2A progenitor 
cells prematurely stopped dividing and differentiated into 
oligodendrocytes (identified by staining with anti-GC anti- 
body); in cultures maintained in PDGF, O-2A progenitor 
cells continued to divide, and the first oligodendrocytes ap- 
pears after 3 d in vitro, which is the equivalent to the day of 
birth, when the first oligodendrocytes  develop in vivo (Miller 
et al.,  1985).  As shown in Table II, cultures maintained in 
PDB plus A23187 behaved similarly to those maintained in 
PDGF: progenitor cells continued to proliferate, and the first 
oligodendrocytes were seen after 3 d in vitro. 
A Combination ofPDGF,, PDB, and A23187 
Does Not Stimulate Newly Formed Oligodendrocytes 
To Synthesize DNA 
To determine if newly formed oligodendrocytes could be 
stimulated to synthesize DNA in response to a combination 
of PDB and A23187  (with or without PDGF), cultures of 
newborn optic nerve cells were maintained in these reagents 
and double labeled with anti-GC and anti-BrdU antibodies 
after 2 d in vitro, having been exposed to BrdU for the last 
24 h of the culture period. In three out of three experiments, 
no  oligodendrocytes  were  induced  to  incorporate  BrdU. 
Adding dbcAMP (10-6-10  -3 M) together with these agents 
did not affect this result. Thus, newly formed oligodendro- 
cytes, which have been shown previously not to synthesize 
DNA in response to PDGF (Hart et al., 1989),  also do not 
respond to a combination of PDB and A23187,  whether or 
not PDGF and dbcAMP are present. 
Downregulation  of C-kinase Does Not Inhibit the 
Ability of PDGF To Stimulate O-2A Progenitor Cells 
To Synthesize DNA 
To determine whether the mitotic effect of PDGF on O-2A 
progenitor cells requires the activation of C-kinase, we cul- 
tured newborn optic nerve cells for 12 h at 37°C in a high 
concentration of PDB  (10  -6 M)  to downregulate C-kinase 
(Collins  and  Rozengurt,  1984).  The  cultures  were  then 
washed and maintained for an additional 36 h with either 
PDGF (2 ng/ml) or PDB (10  -s M) plus A23187  (10  -9 M). 
BrdU was added for the last 24 h  of the culture period. 
Whereas downregulation of C-kinase decreased the DNA 
synthesis response of O-2A progenitor cells to PDB plus 
A23187 from 46 +  3% to3 +  1%, it did not affect their re- 
sponse to PDGF (62 +  6% compared with 58 -I- 5% in con- 
trol cultures). Thus, the ability of PDGF to stimulate O-2A 
progenitor cells to synthesize DNA seems not to depend on 
the activation of C-kinase. 
Discussion 
In the present study we have continued our efforts to under- 
stand the molecular nature of  the timing mechanism that con- 
trols the onset of oligodendrocyte differentiation. Previous 
studies have suggested that the mechanism depends on an in- 
trinsic timer in each O-2A progenitor cell that operates by 
limiting the time, or the number of times, that the cell can 
divide in response to PDGF (Raffet al., 1985, 1988; Temple 
and Raft,  1986).  The question of why many types of cells 
stop dividing and differentiate in the continuing presence of 
growth  factors  is  a  fundamental one  in  vertebrate  devel- 
opment. 
Two types of PDGF receptor proteins have been defined 
(Claesson-Welsh  et al.,  1988;  Gronwald et al.,  1988;  Hart 
et al., 1988; Heldin et al., 1988)-type A and type B-both 
of which are  single-pass transmembrane tyrosine kinases 
(Yarden et al., 1986; Claesson-Welsh et al., 1988; Gronwald 
et al., 1988; Matsui et al., 1989). Cells of the O-2A lineage 
have type A  receptors  (Hart et al.,  1989;  Pringle et al., 
1989).  Although much more is known about the functional 
properties of type B receptors (Williams, 1989),  given that 
both types of receptor have very similar structures (Claes- 
son-Welsh et al., 1989),  it seems likely that they use similar 
signal  transduction mechanisms.  In  experiments  reported 
here, we have examined the possibility that O-2A progenitor 
cells eventually become mitotically unresponsive to PDGF 
because their PDGF receptors become functionally uncou- 
pled from the inositol phospholipid or cAMP signaling path- 
ways. Our results suggest that this is not the case. 
Using fura-2AM to measure cytosolic free Ca  2+, we dem- 
Table II. Effect of  PDB Plus A23187 on O-2A Progenitor 
Cell Proliferation and the Timing of Oligodendrocyte 
Development in Cultures of  Embryonic Day-18 Optic 
Nerve Cells 
Cells in cultures containing 
Time in  PDGF  PDB (10  -~ M)  + 
culture  Celt type  No additives (2 ng/ml) A23187 (10  -~ M) 
d  n  n  n 
1  O-2A progenitors  133  173  148 
Oligodendrocytes  0  0  0 
2  O-2A progenitors  184  299  233 
Oligodendrocytes  14  0  0 
3  O-2A progenitors  168  522  378 
Oiigodendrocytes  58  15  18 
The results represent the total number of progenitor cells and oligodendrocytes 
seen in  three experiments. The cells were  double  labeled  with  A2B5  and 
anti-GC antibodies. Oligodendrocytes were identified  as GC  + ceils, whereas 
O-2A progenitors were identified  as A2B5 +, GC-, process-bearing cells. 
Hart et al. Signaling in Oligodendrocyte Differentiation  3415 onstrated that PDGF stimulates a rapid increase in cytosolic 
Ca  2+ in a proportion of both O-2A progenitor cells, which 
are  mitotically  responsive  to  PDGE  and  newly  formed 
oligodendrocytes, which are not. This indicates that, when 
they are activated,  the  PDGF receptors on at  least  some 
newly  formed oligodendrocytes are  capable of increasing 
cytosolic Ca  2+. If the increase in Ca  2+ is mediated by inosi- 
tol trisphosphate (Berridge,  1988), then this finding would 
indicate that the PDGF receptors on these newly formed 
oligodendrocytes can activate the inositol phospholipid sig- 
naling  pathway.  Even if the  increase  in  cytosolic Ca  2+  is 
mediated by  some other signaling  pathway  (Nhnberg and 
Rozengurt, 1988), our finding raises the possibility that the 
block of mitotic responsiveness in these cells lies downstream 
from the PDGF receptor and some of the early intracellular 
signaling events that follow its activation. 
A second line of experiments strongly supports this possi- 
bility. We found that we could mimic the effects of PDGF on 
O-2A progenitor cells in culture by both increasing cytosolic 
Ca  2÷ with A23187 and activating C-kinase with PDB.  Sin- 
gle-cell experiments showed that both PDGF and the two 
drugs act directly on progenitor cells to stimulate DNA syn- 
thesis.  Not only did the drugs mimic PDGF in stimulating 
progenitor cells to synthesize DNA and to proliferate, they 
also mimicked PDGF in reconstituting the normal in vivo 
timing of oligodendrocyte differentiation in cultures of em- 
bryonic optic nerve cells. Thus, the timing mechanism that 
controls when progenitor cells stop dividing and differentiate 
into oligodendrocytes apparently operates normally when 
the cells are stimulated to divide by drugs that bypass both 
the PDGF receptors and the earliest signaling events that 
they activate. This suggests that these receptors and events 
might not be involved in the timing mechanism. Consistent 
with this view was the finding that the same drugs did not 
stimulate newly formed oligodendrocytes to synthesize DNA, 
even in the presence of PDGE indicating that these cells are 
blocked in their mitotic response somewhere distal to the 
earliest intracellular signaling events in the mitotic pathway. 
All of the results discussed thus far are consistent with the 
possibility that O-2A progenitor cells eventually become un- 
responsive to PDGF and to the combination of A23187 plus 
PDB because C-kinase decreases in concentration or is inac- 
tivated. To indirectly test this possibility, we treated optic 
nerve cultures with a high concentration of PDB for 12 h to 
downregulate C-kinase in O-2A progenitor cells. Whereas 
this treatment abolished the ability of the progenitor cells to 
synthesize DNA in response to A23187 plus PDB, it had no 
effect on the response of  these cells to PDGE This result sug- 
gests that in O-2A progenitor cells, as in other cells, there 
are  multiple,  redundant,  intracellular  signaling  pathways 
from the plasma membrane to the nucleus that lead to cell 
division (Rozengurt,  1986). It also suggests that the ability 
of PDGF to stimulate progenitor cells to synthesize DNA 
does not depend on C-kinase activation, which makes it un- 
likely that the failure of PDGF to stimulate newly formed 
oligodendrocytes to synthesize DNA is due solely to a de- 
crease or inactivation of C-kinase. 
We were unable to stimulate O-2A progenitor cells to syn- 
thesize DNA by increasing the intraceUular concentration of 
cAMP with dbcAMP or forskolin, either alone or in combi- 
nation with A23187 or PDB. Nor were we able to stimulate 
newly formed oligodendrocytes to synthesize DNA by these 
treatments, even when combined with PDGE making it un- 
likely that the mitotic unresponsiveness of these cells is due 
to a block in generating cAMP. 
Taken together, our results suggest that O-2A progenitor 
cells normally become mitotically unresponsive to PDGF 
because they develop a block downstream from the PDGF 
receptor and some of the early events that follow its activa- 
tion, including the increase in cytosolic Ca  2+ and the activa- 
tion of C-kinase. Although we cannot exclude the possibility 
that some early events that normally follow PDGF receptor 
activation (that we did not examine) fail to occur, this could 
not be the sole cause of the mitotic unresponsiveness. We 
need to look next at those parts of the mitotic intracellular 
signaling pathways that lie closer to the nucleus or within the 
nucleus itself. 
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